REGN
RegeneronCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
REGN vs peer average
53/100
REGN vs. peer average (C vs. C)
Grade spread
B 3 · C 3 · D 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Broad large-cap biotech comparator from the packet, not a direct retina-franchise peer. It is mainly useful for comparing how investors value mature biologics cash flow, pipeline reinvestment, and capital returns across diversified biotech models.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
REGN
Regeneron
AMGN
Amgen
Grade
C
D
Momentum
25
35
Value
65
63
Sentiment
59
33
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs AMGN
REGN / AMGN
Grade Position
In line
REGN vs. peer average (C vs. C)
53/100
Momentum
25
AMGNValue
65
REGNSentiment
59
REGNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs REGN
AMGN is the first peer returned for this comparison set.